Evidence map›Paper›PMID 29788137›Full record

Trial reportInflammatory bowel diseases2018

Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year.

Ameer Abutaleb, Andrea Buchwald, Kenechukwu Chudy-Onwugaje, Patricia Langenberg, Miguel Regueiro, David A Schwartz, J Kathleen Tracy, Leyla Ghazi, Seema A Patil, Sandra M Quezada and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Inflammatory bowel diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Remote care through telehealth for people with inflammatory bowel disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Doctor Will Call You Now! Telemedicine in the Midst of a Pandemic.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020
    Article
  12. Remote Monitoring and Telemedicine in IBD: Are We There Yet?Current gastroenterology reports · 2020
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ameer AbutalebUniversity of Maryland School of Medicine, Baltimore, Maryland.
Andrea BuchwaldUniversity of Maryland School of Medicine, Baltimore, Maryland.
Kenechukwu Chudy-OnwugajeUniversity of Maryland School of Medicine, Baltimore, Maryland.
Patricia LangenbergUniversity of Maryland School of Medicine, Baltimore, Maryland.
Miguel RegueiroUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
David A SchwartzVanderbilt University School of Medicine, Nashville, Tennessee.
J Kathleen TracyUniversity of Maryland School of Medicine, Baltimore, Maryland.
Leyla GhaziDartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Seema A PatilUniversity of Maryland School of Medicine, Baltimore, Maryland.
Sandra M QuezadaUniversity of Maryland School of Medicine, Baltimore, Maryland.
Katharine M RussmanUniversity of Maryland School of Medicine, Baltimore, Maryland.
Charlene C QuinnUniversity of Maryland School of Medicine, Baltimore, Maryland.
Guruprasad JambaulikarBrigham and Women's Hospital, Boston, Massachusetts.
Dawn B BeaulieuVanderbilt University School of Medicine, Nashville, Tennessee.
Sara HorstVanderbilt University School of Medicine, Nashville, Tennessee.
Raymond K CrossUniversity of Maryland School of Medicine, Baltimore, Maryland.

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
TELEmedicine in Patients with Inflammatory Bowel Disease: TELE-IBDR01HS018975 · AHRQ · UNIVERSITY OF MARYLAND BALTIMORE · PI CROSS, RAYMOND KEITH · 2012 to 2014
$1.1M
AHRQ HHS R01 HS018975NIDDK NIH HHS T32 DK067872
6 · The paper itself

Abstract

Background: Effective treatments are available for patients with inflammatory bowel disease (IBD); however, suboptimal outcomes occur and are often linked to patients' limited disease knowledge. The aim of this analysis was to determine if delivery of educational messages through a telemedicine system improves IBD knowledge. Methods: TELEmedicine for Patients with IBD (TELE-IBD) was a randomized controlled trial with visits at baseline, 6 months, and 12 months; patient knowledge was a secondary aim of the study. Patients were randomized to receive TELE-IBD every other week (EOW), weekly (TELE-IBD W), or standard of care. Knowledge was assessed at each visit with the Crohn's and Colitis Knowledge (CCKNOW) survey. The primary outcome was change in CCKNOW score over 1 year compared between the TELE-IBD and control groups. Results: This analysis included 219 participants. Participants in the TELE-IBD arms had a greater improvement in CCKNOW score compared with standard care (TELE-IBD EOW +2.4 vs standard care +1.8, P = 0.03; TELE-IBD W +2.0 vs standard care +1.8, P = 0.35). Participants with lower baseline CCKNOW scores had a greater change in their score over time (P < 0.01). However, after adjusting for race, site, and baseline knowledge, there was no difference in CCKNOW score change between the control and telemedicine arms. Conclusions: Telemedicine improves IBD-specific knowledge through text messaging, although the improvement is not additive with greater frequency of text messages. However, after adjustment for confounding variables, telemedicine is not superior to education given through standard visits at referral centers. Further research is needed to determine if revised systems with different modes of delivery and/or frequency of messages improve disease knowledge.

Indexed as

Health Knowledge, Attitudes, PracticePatient Education as TopicQuality of LifeAdultFemaleFollow-Up StudiesHumansInflammatory Bowel DiseasesMalePrognosisSurveys and QuestionnairesTelemedicineText MessagingTime Factors

Identifiers

PMID29788137
PMCPMC7190916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.